Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16
eLife · 2023
DOI: 10.7554/elife.87884 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2023. Verfasst von Huan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: COVID-19, Viral Regulatory and Accessory Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
The coronavirus SARS-CoV-2 protects its RNA from being recognized by host immune responses by methylation of its 5’ end, also known as capping. This process is carried out by two enzymes, non-structural protein 16 (NSP16) containing 2’-O-methyltransferase and NSP14 through its N7 methyltransferase activity, which are essential for the replication of the viral genome as well as evading the host’s innate immunity. NSP10 acts as a crucial cofactor and stimulator of NSP14 and NSP16. To further understand the role of NSP10, we carried out a comprehensive analysis of >13 million globally collected whole-genome sequences (WGS) of SARS-CoV-2 obtained from the Global Initiative Sharing All Influenza Data (GISAID) and compared it with the reference genome Wuhan/WIV04/2019 to identify all currently known variants in NSP10. T12I, T102I, and A104V in NSP10 have been identified as the three most frequent variants and characterized using X-ray crystallography, biophysical assays, and enhanced sampling simulations. In contrast to other proteins such as spike and NSP6, NSP10 is significantly less prone to mutation due to its crucial role in replication. The functional effects of the variants were examined for their impact on the binding affinity and stability of both NSP14-NSP10 and NSP16-NSP10 complexes. These results highlight the limited changes induced by variant evolution in NSP10 and reflect on the critical roles NSP10 plays during the SARS-CoV-2 life cycle. These results also indicate that there is limited capacity for the virus to overcome inhibitors targeting NSP10 via the generation of variants in inhibitor binding pockets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University College London, London, United Kingdom.
- College of Engineering, Design and Physical Sciences, Brunel University London, Uxbridge, United Kingdom.
- High-Performance Computing Center, Oklahoma State University, Stillwater, United States.
- Department of Physiological Sciences, Oklahoma State University, Stillwater, United States.
- UCL Centre for Advanced Research Computing, University College London, London, United Kingdom.
ORCID-Profile: Pratul K Agarwal, Shozeb Haider
Förderung
- Medical Research Council
Zitieren
APA
Wang, H., Rizvi, S. R. A., Dong, D., Lou, J., Wang, Q., Sopipong, W., Su, Y., Najar, F., Agarwal, P. K., Kozielski, F., & Haider, S. (2023). Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16. eLife. https://doi.org/10.7554/elife.87884
Vancouver
Wang H, Rizvi SRA, Dong D, Lou J, Wang Q, Sopipong W, et al. Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16. eLife. 2023. doi:10.7554/elife.87884
BibTeX
@article{Wang2023,
author = {Wang, Huan and Rizvi, Syed R A and Dong, Danni and Lou, Jiaqi and Wang, Qian and Sopipong, Watanyoo and Su, Yufeng and Najar, Fares and Agarwal, Pratul K and Kozielski, Frank and Haider, Shozeb},
title = {Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16},
journal = {eLife},
year = {2023},
doi = {10.7554/elife.87884}
}
EUVIMED